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1143-135 The Risk of Prosthetic Valve Endocarditis in Patients 
With Staphylococcus Aureus Bacteremia
Fadi M. El-Ahdab, Andrew Wang, Christopher Cabell, Barth Reller, Ralph Corey, Daniel 
Sexton, Vance Fowler, Duke University Medical Center, Durham, NC
Background: A major complication of prosthetic valves is prosthetic valve endocarditis
(PVE). Staphylococcus aureus is a common cause of bacteremia and of infective
endocarditis (IE) of native heart valves. However, there are limited data about the risk of
IE in patients with a prosthetic valve and Staphylococcus aureus bacteremia (SAB). The
aim of this study was to define the incidence of PVE in patients with SAB.
Methods: In order to define the risk of PVE, we prospectively evaluated all patients with
a prosthetic valve or ring (PV) who presented to our hospital and developed SAB. Duke
criteria for IE were used for the diagnosis of PVE. All patients were followed up for 12
weeks after diagnosis of SAB.
Results: Fifty-two patients met the criteria over a 94-month study period. The overall rate
of definite PVE was 26/52 (50%). The risk of PVE was similar in patients with late SAB
(more than 12 months after PV implantation) and those with early SAB (less than 12
months after PV implantation). The risk was also comparable among patients with a
mitral prosthesis and those with an aortic prosthesis (55% vs. 46%). The presumed
source of SAB was a surgical wound in 21 patients, an intravascular device (IV catheter,
hemodialysis graft) in 9 patients, IV drug use in 4 patients, other tissue source in 3
patients, and unidentifiable in 15 patients. MRSA was present in 36% of the patients. The
12-week mortality among patients with PVE was 46%.
Conclusion: Among patients who develop SAB in the presence of a PV, 50% will be
diagnosed with PVE regardless of the time from valve implantation to the onset of SAB.
The diagnosis of PVE carries a high mortality rate. All patients with SAB in the presence
of a prosthetic valve should be aggressively screened for PVE.
1143-136 Prosthetic Valve Endocarditis: Report of 214 Cases 
From the Intracardiac Echocardiography Prospective 
Cohort Study
Christopher H. Cabell, G. Ralph Corey, Bruno Hoen, Jose M. Miro, Diana Iarussi, 
Christine Selton-Suty, Andrew Wang, Eugene Athan, Sandra Braun, Philip Jones, 
Stamatios Lerakis, Shabaz Hasan, Miguel Oyonarte, Vance G. Fowler, Jr., The ICE 
Investigators, Duke Clinical Research Institute, Durham, NC
Background: Prosthetic valve endocarditis (PVE) is an emerging but incompletely
understood complication of medical progress.
Aim of Study: To determine the current clinical characteristics and outcome of patients
with PVE utilizing the International Collaboration on Endocarditis (ICE) Prospective
Cohort Study (ICE-PCS).
Methods: From January 2000 through November 2002, 1024 cases of definite IE were
prospectively enrolled by 34 centers representing 15 countries using a standard case
report form. Of these, 214 (20.8%) had PVE.
Results: The median age of PVE patients was 59.5 years (IQR 47.0-73.0); 69.2% were
male. The interval from valve surgery to onset of PVE was < 60 days in 21 patients and >
365 days in 69 patients (median = 447.5 days, IQR 104 – 2329 days). The most common
organisms were Staphylococcus aureus (25.8%), coagulase negative staphylococci
(18.3%), and viridans group streptococci (11.7%). PVE was demonstrated by echocar-
diography in 146 patients (92.4%): vegetations (70.6%), abscess (32%), dehiscence
(15%), and fistula (1%). Surgery during the acute episode was common (52.3%) with
valve regurgitation (54.5%) and abscess (42.0%) the most frequent indications. Embolic
events (stroke 13.5%, other emboli 13.2%), heart failure (31.2%), intracardiac abscess
(33.2%), and death (23.8%) were frequent complications of PVE.
Conclusion: In this large, multicenter, international cohort, S. aureus was the most com-
mon cause of PVE. Although over 50% of patients went to surgery, mortality remained
high. Further work is needed to evaluate the emerging importance of S. aureus as a
cause of PVE, to identify risk factors for death, and to define the impact of early surgery
on survival.
1143-137 Echocardiographic Features of Definite Infective 
Endocarditis: A French Collaborative Study on 561 
Cases
Christine Selton-Suty, Raymond Roudaut, Yvette Bernard, Pierre Nazeyrollas, Eric 
Garbarz, François Alla, Thanh Doco-Lecompte, Anne Bouvet, François Vandenesch, 
Catherine Leport, Bruno Hoen, François Delahaye, AEPEI, Paris, France
Aim of the study: To describe echocardiographic (Echo) features of definite infective
endocarditis (IE) in the Duke criteria era
Methods: We reviewed the charts of 561 pts included in the French survey on IE (1999).
The case report form included information on clinical and microbiological characteristics
of IE. Specific Echo data included transthoracic (TTE) and transesophageal (TEE)
description of valve lesions for each infected valve: vegetation (Vg), abscess (Ab), pros-
thetic dehiscence (PD), perforation (Perf), significant regurgitation (Reg).
Results: Among 561 pts (mean age : 59±17 yrs), Echo revealed a Vg in 487 pts (87%),
an Ab in 92 (16%), a Reg in 476 (85%) and a PD in 20 (23%). Site of IE could not be
identified precisely in 49 pts (9%). 
Among the 400 cases for whom TTE and TEE findings could be clearly separated, TEE
proved to be more accurate in 238 (60%), yielding an additional identification of a Vg, an
Ab, a Perf and a PD in 187 (47%), 55 (14%), 15 (4%) and 6 (1%) pts respectively.
Among the 264 pts (47%) treated surgically, information on macroscopic findings were
available in 224. Comparison between Echo and macroscopic findings were in complete
agreement in 126 pts (56%), but differed concerning the diagnosis of Vg in 52 pts (23%),
Ab in 29 (13%), Perf in 41 (18%), and PD in 2.
When sorting responsible micro-organisms in 5 groups (1: staphylococci n=167, 2: strep-
tococci n=270, 3: enterococci n=46, 4: others n=49, and 5: none identified n=29) and
comparing Echo findings among them, there was a trend towards a lower frequency of
Vg in enterococcal IE (1: 90%, 2: 87%, 3: 74%, 4: 88%, 5: 86%, p<.09), a lower rate of Ab
in staphylococcal IE (1: 12%, 2: 17%, 3: 26%, 4: 25%, 5: 10%, p<.07) and a higher fre-
quency of Reg in streptococcal IE (1: 78%, 2: 92%, 3: 87%, 4: 80%, 5: 69%, p<.001)
A Vg was found more often in pts with vascular phenomena (p<.002) and embolic event
(p<.001). Pts with Ab (p<.001), Reg (p<.001) or PD (p<.04) were more often operated on
than those without.
Conclusion: TEE is of great importance for the diagnosis of IE. However, when compared
to surgical findings, accuracy of TEE for description of valve lesions often remains subop-
timal. Echocardiographic patterns may differ according to responsible micro-organisms.
1143-138 Prognostic Implications of Vegetation Size at Hospital 
Admission in Infective Endocarditis
Maria Luaces- Mendez, Cristina Sarria, Jose Alberto San Roman, Cristina Fernandez, 
Javier Lopez, Cecilia Corros, Isidre Vilacosta, Hospital Clinico Universitario San Carlos, 
Madrid, Spain
BACKGROUND: The information obtained from echocardiography in infective endocardi-
tis is employed with prognostic aims. We assessed the hypothesis that vegetation size in
the first transesophageal study (TEE) has prognostic implications in the clinical course of
infective endocarditis. METHODS: We analyzed 265 consecutive episodes of infective
endocarditis with vegetations documented on the first TEE. The relative risk obtained
from the univariate analysis was adjusted by a logistic regression model including the fol-
lowing variables: age, acute or subacute course, underlying heart disease, microorgan-
ism, valve (native, mechanical, biological), position of the valve and embolisms before
institution of correct antibiotic treatment. A cut-off value of vegetation size for risk
increase was calculated according to quartile distribution of vegetation size. RESULTS:
On the multivariate analysis, vegetation size resulted to be an independent factor for the
following events: septic shock, persistent infection, renal failure and need for surgery.
Clinically, risk was increased for vegetation size > 20 mm (upper quartile, table). CON-
CLUSIONS: Vegetation size in the first TEE predicts the development of septic shock,
signs of persistent infection, renal failure, and the need for surgery. The risk of these
complications is particularly relevant when the vegetation size is > 20mm. 
1143-139 Hepatosplenic and Renal Embolisms in Infective 
Endocarditis
Maria Luaces- Mendez, Jose Alberto San Roman, Cristina Sarria, Cristina Fernandez, 
Cecilia Corros, Javier Lopez, Isidre Vilacosta, Hospital Clinico Universitario San Carlos, 
Madrid, Spain
BACKGROUND: As one of the complications of infective endocarditis, embolization has
a great impact on prognosis. We assessed the epidemiological, clinical, microbiological,
echocardiographic and prognostic features of episodes of infective endocarditis with
symptomatic embolisms in the hepatosplenic circulation or the kidney. METHODS: We
studied 338 consecutive episodes of left-sided infective endocarditis. Embolisms were
documented by abdominal ultrasound and/or computed tomography. RESULTS: There
were 40 embolisms (33 at the spleen, 5 at the kidney, and 2 at the liver) in 33 episodes
(9.7%) of endocarditis (group I). The remaining 305 episodes form the group II. Different
characteristics in both groups are summarized in the table. In 2 episodes non-cardiac
surgery was performed: splenectomy in one, renal biopsy in other. Cardiac surgery rates
were comparable and mortality was higher in group I. On the logistic regression analysis,
embolisms were not an independent factor associated to higher mortality nor to valve
surgery. CONCLUSIONS: In left-sided infective endocarditis complicated with embolisms
in the hepatosplenic circulation or the kidney: 1) Detection of vegetations by transesoph-
ageal echocardiography is more frequent and they are larger. 2) S. aureus and entero-
Adj RR 95% CI P value
NEED FOR SURGERY Overall 1.08 1.03- 1.13 0.002
Vegetation size > 20 mm 6.13 2.02- 18.50 < 0.001
SEPTIC SHOCK Overall 1.08 1.00- 1.16 < 0.001
Vegetation size > 20 mm 21.48 1.49- 307.93 0.02
PERSISTENT 
INFECTION
Overall 1.05 1.01- 1.10 0.02
Vegetation size > 20 mm 3.32 1.10- 9.99 0.03
RENAL FAILURE Overall 1.04 0.99- 1.09 0.06
Vegetation size > 20 mm 2.38 0.73- 7.75 0.15












cocci are more common. 3) Embolisms in other locations are more frequent. 4) Septic
shock is more frequent. 5) Death and the need for valve surgery are not influenced by the
existence of these embolisms. 
1143-140 Reoperative Valve Replacement With the St. Jude 
Medical Valve Prosthesis: Long-Term Follow-Up
Robert W. Emery, Kit V. Arom, Christopher Krogh, Lyle D. Joyce, Demetre Nicoloff, 
Minnesota Cardiovascular & Thoracic Surgeons, LLC, St. Paul, MN
OBJECTIVE: From 6/78 – 9/02, 451 redo open heart patients (following various primary
cardiac operations) age range 18-91 years (average age 62 ± 14) underwent single-valve
replacement with the St. Jude Medical (SJM) heart valve. Of 248 patients having aortic
(AVR) and 203 patients having mitral valve replacements (MVR), 35% and 21% had con-
comitant coronary bypass respectively.
METHODS: Cardiac Surgical Associates has maintained an independent database of
our patients with the SJM prosthesis since the world’s first implant in 10/77. Patients were
contacted by questionnaire and/or phone from 11/02 through 6/03. Hospital course and
valve-related events were verified by patient chart review and/or physician contact.
RESULTS: Follow-up was 95% complete for a total of 3,115 patient years (1,671 AVR;
1,443 MVR). Follow-up ranged from 0.1 to 24.3 years (average 7 ± 6 years). Operative
mortality was 9% (10% AVR, 8% MVR). Five deaths (13%) were valve related. Freedom
from all late mortality at 24 years was 64% (70% AVR, 56% MVR), and from valve-related
mortality 83% (84% AVR, 82% MVR). Freedom from thromboembolic events was 85%
(91% AVR, 82% MVR), from bleeding events 83% (83%AVR, 82% MVR), from
endocarditis 97% (97% AVR, 97% MVR), from valve thrombosis 98% (99% AVR, 98%
MVR), and from subsequent reoperation 94% (95% AVR, 94% MVR),. There were no
structural failures.
CONCLUSION: Reoperative valve replacement carries a significant operative mortality,
but long term results with the SJM valve show a low event rate, a durable prosthetic valve
and excellent long-term patient survival.
ORAL CONTRIBUTIONS
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851-1 Ischemic Mitral Regurgitation Does Not Influence 
Postinfarction Ventricular Remodeling
Sina L. Moainie, Yoshiharu Enomoto, Joseph H. Gorman, III, Benjamin M. Jackson, 
Theodore Plappert, Martin G. St. John-Sutton, Ahmad Zeeshan, Robert C. Gorman, 
University of Pennsylvania, Philadelphia, PA
Background: Despite sparse clinical data, surgical treatment for ischemic mitral regurgi-
tation (IMR) has become more aggressive. We used four well-developed ovine models of
postinfarction left ventricular (LV) remodeling to test the hypothesis that IMR does not sig-
nificantly contribute to postinfarction LV remodeling.
Methods: Infarction of 21% to 24% of the LV was induced by coronary ligation in 71
sheep. Infarctions varied only by anatomic location: anteroapical (AA), n=26; anterobasal
(AB), n=16; laterobasal (LB), n=9 and posterobasal (PB) n= 20. End systolic volume
(ESV), end diastolic volume, end systolic muscle to cavity area ratio (ESMCAR), ejection
fraction (EF) and degree of IMR as determined by quantitative echocardiography were
assessed before infarction and at 2, 5 and 8 weeks after infarction to evaluate the extent
of LV remodeling.
Results: All infarcts resulted in significant postinfarction remodeling and decreased EF
(table). AA infarcts led to LV aneurysms and resulted in more severe remodeling than the
three other infarct locations. Only PB infarcts caused severe and progressive IMR.
Remodeling due to PB infarcts was not more severe than that caused by infarcts at other
locations.
Conclusion: The extent of postinfarction remodeling is determined by infarct size and
location. The development of IMR does not contribute to adverse remodeling. IMR is a
manifestation rather than a cause of postinfarction remodeling. The current aggressive
surgical approach to IMR should be reassessed. 
2:15 p.m.
851-2 Reduction in Functional Mitral Regurgitation Using the 
Coapsys Annuloplasty Device in Patients Undergoing 
Off-Pump Coronary Artery Bypass Grafting: A 
Quantitative Echo Analysis
Sanjay Mittal, Yugal Mishra, Yatin Mehta, Naresh Trehan, Escorts Heart Institute and 
Research Centre, New Delhi, India
Background: We are evaluating a novel implantable device (Myocor® Coapsys™ Annu-
loplasty System) intended to treat functional mitral regurgitation (MR) on a beating heart
as conventional surgical correction increases mortality and morbidity over CABG alone.
Changes in mitral valve (MV) geometry induced by the device were evaluated using echo
techniques.
Methods: The Coapsys device was surgically implanted in 20 patients (mean age 58.7 ±
8.1 years, 3 females, mean ejection fraction 37.3 ± 6.2 %) with sustained MR grade 2 or
more after undergoing concomitant CABG. Patients with structural abnormalities of the
MV or its apparatus were excluded . Coapsys consists of anterior and posterior epicardial
pads connected by a flexible sub-valvular chord. The device is tightened under echo
guidance to minimize MR. Echo parameters (MR Grade; Maximum MR jet area; end-
diastolic antero-posterior (A-P) annular dimension and MV tenting area) were studied
pre-operatively and post-operatively (prior to discharge and 3 months).
Results: Implants were performed off-pump without device related adverse events. Echo
parameters were as Table 1. [* p<0.005 compared to pre-implantation]
Table 1 
Conclusions: The Coapsys device can be safely implanted on the beating heart.
Implantation of the device results in significant reductions in MR. MR jet area, A-P dimen-
sion, and MV tenting area are also significantly reduced. These functional and geometric
changes are maintained at 3-months.
2:30 p.m.
851-3 Staged Initial Percutaneous Coronary Intervention 
Followed by Valve Surgery (“Hybrid” Approach) for 
Patients With Complex Coronary and Valve Disease
John G. Byrne, Marzia Leacche, Tomislav Mihaljevic, Sary F. Aranki, James D. Rawn, 
Lawrence H. Cohn, Brigham and Women's Hospital, Boston, MA
Background:With advancements in percutaneous coronary interventions (PCI), some
patients requiring coronary revascularization and valve surgery may be better served
with a “hybrid” approach involving initial planned PCI followed by valve surgery in a
staged fashion rather than conventional high-risk valve/CABG. This may be particularly
relevant in hemodynamically unstable patients after acute coronary syndromes, and
some patients requiring valve reoperations.
Methods: We retrospectively analyzed 26 consecutive patients with coronary artery and
valve disease who were treated with planned initial PCI followed by valve surgery during
the same hospitalization between September 1997 and August 2003.
Results: Median age was 72.5 years (range 53-91 years), with 12M/14F. Mean NYHA
was 3.5±0.6. Acute myocardial infarction was present in 10/26 (38%) with cardiogenic
shock in 4/26 (15%) and low cardiac output syndrome in 6/26 (23%). 7/26 (27%) required
preoperative intubation. Balloon angioplasty was performed in every patient (n=26), fol-
Group I








Prosthetic endocarditis 30.3 36.7 0.46
Embolisms in other locations 48.5 13.4 <0.001
Stroke at admission 33.3 15.1 0.008
Splenomegaly 24.2 10.9 0.04
S. aureus 30.3 16.1 0.04
Enterococci 18.2 8.2 0.05
Vegetations detected by TEE 97.0 78.0 0.01
Vegetation Size _10 mm 90.0 70.8 0.02
Septic shock 27.3 9.5 0.002
Persistent infection 54.5 32.8 0.01
Surgery 54.5 53.1 0.87
Mortality 39.4 30.8 0.31
Infarct Location IMR at 8 weeks
(0=no MR, 
4=severe MR)
ESV at 8 
weeks as % of 
preinfarction
ESMCAR at 
8weeks as % of 
preinfarction
EF at 8 weeks 




0.7± 0.2 238±11* 86± 4 76± 34
Anterobasal(AB) 
n=16
0.5± 0.2 203±17 75±6 75± 38
Laterobasal(LB)
n=9
0.2± 0.2 191±19 83± 8 74± 23
Posterobasal(PB) 
n=20
2.8± 0.2** 218±12 74± 7 73± 21
* ESV significantly greater for AA infarcts than all other infarct locations at 8 wks
** IMR significantly greater for PB infarcts than all other infarct locations at 8 wks
Pre-implant Discharge Three Month
MR Grade 3.0±0.6 1.1±1.0* 1.3±0.8*
MR jet area (cm²) 7.9±3.7 3.5±2.0* 3.6±1.6*
Annular A-P Dimension 2.8±0.4 2.4±0.4* 2.6±0.4*
Mitral Tenting Area 3.9±1.0 2.8±1.0* 2.9±0.9*
